Nexgel, Inc.
NXGL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $293.0K in total; no superinvestor holds it.
Other share classesNXGLW
Key figures
- Market capClose on Nov 17, 2026
- $2.04M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 19
- 13F valueReported value at the end of Q2 2026
- $293.0K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $11.4M
- +31.5% year over year
- Net income, FY2025
- -$3.00M
- No comparable prior period
- Free cash flow, FY2025
- -$1.38M
- No comparable prior period
- Revenue, Q3 FY2026
- $3.18M
- +8.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $3.00M (26.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 24.0K
- Shares sold short
- Change
- −80.7K
- −77.0% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding NXGL, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NXGL at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Nexgel, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 (view filing)9:59 PM ET | Nov 10 | 3 days | Kieser Brian JosephInterim CEO | PPurchase | +133.2K | $5.50 | +$732.7K | New position133.2K after | Price outlier |
| Nov 13, 2026 (view filing)9:59 PM ET | Nov 10 | 3 days | Kieser Brian JosephInterim CEO | PPurchase | +133.2K | $0.00 | $0 | –133.2K after | Derivative |
| Nov 13, 2026 (view filing)9:58 PM ET | Nov 10 | 3 days | glassman steven markDirector | PPurchase | +4.55K | $5.50 | +$25.0K | +58.0%12.4K after | Price outlier |
| Nov 13, 2026 (view filing)9:58 PM ET | Nov 10 | 3 days | glassman steven markDirector | PPurchase | +4.55K | $0.00 | $0 | –4.55K after | Derivative |
| Jun 23, 2026 (view filing) | Jun 18-23 | 5 days | Levy Adam R.Chief Executive Officer | SSale | −11.0K | $0.59 | −$6.49K | −3.3%322.7K after | 2 lots |
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Levy Adam R.Chief Executive Officer | SSale | −3.00K | $0.61 | −$1.83K | −0.9%333.7K after | |
| Jun 9, 2026 (view filing) | Jun 4-8 | 5 daysLate | Levy Adam R.Chief Executive Officer | SSale | −6.00K | $0.57 | −$3.42K | −1.8%336.7K after | 2 lots |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Levy Adam R.Chief Executive Officer | SSale | −2.00K | $0.59 | −$1.18K | −0.6%342.7K after | |
| May 29, 2026 (view filing) | May 27-29 | 2 days | Levy Adam R.Chief Executive Officer | SSale | −13.0K | $0.6054 | −$7.87K | −3.6%344.7K after | 3 lots |
| May 18, 2026 (view filing) | May 14 | 4 days | Henry Scott RobertDirector | PPurchase | +62.5K | $0.40 | +$25.0K | –20.8K after | Derivative2 lots |
Top 10 13F holders, Q2 2026
See all 19 holdersThe largest institutional positions in Nexgel, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 85,140 | $42.7K | 0.00% | +85,140 | New |
| Virtu Financial LLC | 79,128 | $40.0K | 0.00% | +79,128 | New |
| Geode Capital Management, LLC | 71,863 | $36.0K | 0.00% | −56,673−44.1% | Reduced |
| HRT Financial LP | 69,485 | $34.0K | 0.00% | +53,989+348.4% | Added |
| Morgan Stanley | 54,980 | $27.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 48,920 | $24.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,976 | $20.5K | 0.00% | +40,976 | New |
| Vanguard Fiduciary Trust Co | 34,040 | $17.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24,735 | $12.4K | 0.00% | +18,101+272.9% | Added |
| Jane Street Group, LLC | 20,606 | $10.3K | 0.00% | −21,532−51.1% | Reduced |
Holders of 5% or more of NXGL
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Nexgel, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Asymmetry Point LP | 13G/A | 8.80%745.0K shares | +1.31 ppfrom 7.49% | Mar 12, 20262 filings | Apr 29, 2026 | SEC |